AU3946395A - Chelate complex with high conspicuity for magnetic resonance imaging - Google Patents

Chelate complex with high conspicuity for magnetic resonance imaging

Info

Publication number
AU3946395A
AU3946395A AU39463/95A AU3946395A AU3946395A AU 3946395 A AU3946395 A AU 3946395A AU 39463/95 A AU39463/95 A AU 39463/95A AU 3946395 A AU3946395 A AU 3946395A AU 3946395 A AU3946395 A AU 3946395A
Authority
AU
Australia
Prior art keywords
contrast agent
contrast
agent
carrier
signal intensity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39463/95A
Other languages
English (en)
Inventor
Alexander V. Kachur
Frank L Lexa
Alan C Rosenquist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of AU3946395A publication Critical patent/AU3946395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/146—Peptides, e.g. proteins the peptide being a polyamino acid, e.g. poly-lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AU39463/95A 1994-10-03 1995-10-03 Chelate complex with high conspicuity for magnetic resonance imaging Abandoned AU3946395A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31726794A 1994-10-03 1994-10-03
US317267 1994-10-03
PCT/US1995/012693 WO1996010359A1 (fr) 1994-10-03 1995-10-03 Complexe de chelates a perceptibilite elevee pour l'imagerie par resonance magnetique

Publications (1)

Publication Number Publication Date
AU3946395A true AU3946395A (en) 1996-04-26

Family

ID=23232878

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39463/95A Abandoned AU3946395A (en) 1994-10-03 1995-10-03 Chelate complex with high conspicuity for magnetic resonance imaging

Country Status (4)

Country Link
JP (1) JPH10509424A (fr)
AU (1) AU3946395A (fr)
CA (1) CA2201750A1 (fr)
WO (1) WO1996010359A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000086538A (ja) * 1998-09-17 2000-03-28 Toshihiro Akaike Ｍｒｉ用造影剤
US7097826B2 (en) * 1999-12-23 2006-08-29 Health Research, Inc. Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
DE10325752A1 (de) * 2003-06-06 2004-12-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Lektin-Konjugate
WO2005080032A1 (fr) * 2004-02-20 2005-09-01 Kazunori Kataoka Procédé de fabrication de colloïde de fer, et micelle polymère porteuse de colloïde de fer
CA2575649C (fr) 2006-01-25 2015-04-14 University Of Victoria Innovation And Development Corporation Nanoparticules riches en lanthanides et leurs utilisations en investigation par irm ou au moyen de technologies connexes
JP2010529090A (ja) * 2007-06-08 2010-08-26 ベルゲン・テクノロジオーヴァーフォリング・アクティーゼルスカブ 常磁性生体分子複合体および器官機能の評価におけるその使用
EP2327395A1 (fr) 2009-11-23 2011-06-01 Bracco Imaging S.p.A Procédé de préparation d'un complexe de gadobénate et de diméglumine sous forme solide
CN103582497A (zh) * 2011-04-06 2014-02-12 西奈医疗中心 用于成像的基于聚苹果酸的纳米缀合物
EP3554560A4 (fr) * 2016-12-16 2020-07-29 The Australian National University Matériau radiomarqué pour administration ciblée

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
AU6621586A (en) * 1985-11-18 1987-06-02 University Of Texas System, The Polychelating agents for image and spectral enhancement (and spectral shift)
US5057313A (en) * 1986-02-25 1991-10-15 The Center For Molecular Medicine And Immunology Diagnostic and therapeutic antibody conjugates
DE3806795A1 (de) * 1988-02-29 1989-09-07 Schering Ag Polymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5358702A (en) * 1990-04-10 1994-10-25 Unger Evan C Methoxylated gel particle contrast media for improved diagnostic imaging

Also Published As

Publication number Publication date
CA2201750A1 (fr) 1996-04-11
JPH10509424A (ja) 1998-09-14
WO1996010359A1 (fr) 1996-04-11

Similar Documents

Publication Publication Date Title
EP0247156B1 (fr) Agents polychelateurs pour l'amelioration de l'image et du spectre (et pour derive spectrale)
US5310539A (en) Melanin-based agents for image enhancement
AU624132B2 (en) Contrast agents for magnetic resonance imaging
EP0160552B1 (fr) Agents de contraste pour la formation d'images par résonance magnétique nucléaire
Stark et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver.
US5260050A (en) Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes
US5336762A (en) Polychelating agents for image and spectral enhancement (and spectral shift)
AU628403B2 (en) Methods and compositions for magnetic resonance imaging
CA2079688A1 (fr) Agents diagnostiques
US5458870A (en) Compositions for magnetic resonance imaging using a manganese oxalate
JPS6058136A (ja) Ｎｍｒ診断用画像形成法
AU3946395A (en) Chelate complex with high conspicuity for magnetic resonance imaging
CA2660717A1 (fr) Procedes d'imagerie du systeme lymphatique
AU623408B2 (en) Magnetic particle-containing compositions
EP0896546A2 (fr) Procede d'imagerie par resonance magnetique en ponderation t1 pour les organes du sre
Runge et al. Experimental trials with Gd (DO3A)—a nonionic magnetic resonance contrast agent
Orang-Khadivi et al. New magnetic resonance imaging techniques for the detection of breast cancer
Weissleder et al. Polymeric contrast agents for MR imaging of adrenal glands
Amanlou et al. Magnetic resonance contrast media sensing in vivo molecular imaging agents: an overview
JPH0586380B2 (fr)
Gibby MRI Contrast Agents
Adzamli et al. Macromolecular infarct-specific magnetic resonance contrast agents
Minazzi Bifunctional chelating agents: chemoenzymatic approach and application to DCE-MRI
Clanton Magnetic Resonance Imaging Contrast Agents and the Nuclear Pharmacist